Biomaterials and Gene Therapy: A Smart Combination for MSC Musculoskeletal Engineering

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Gene Therapy

Background:

• Musculoskeletal pathologies present significant challenges for regenerative medicine, particularly concerning bone and cartilage defects.
• Limitations in bone tissue engineering include defect size, vascularization needs, and matrix synthesis.
• Cartilage's avascular nature and limited regenerative capacity necessitate advanced therapeutic strategies.

Purpose of the Study:

• To review in vitro and in vivo studies combining mesenchymal stem cells (MSCs), biomaterials, and gene therapy for bone and cartilage engineering.
• To explore strategies for overcoming challenges in musculoskeletal tissue regeneration.
• To highlight the synergistic potential of MSCs, biomaterials, and gene therapy in tissue repair.

Main Methods:

• Review of in vitro and in vivo studies focusing on the combination of MSCs, biomaterials, and gene therapy.
• Analysis of studies investigating the differentiation potential of MSCs (chondrogenic/osteogenic).
• Examination of biomaterial applications for defect filling and cell modulation.

Main Results:

• Mesenchymal stem cells (MSCs) show promise due to self-renewal, plasticity, and immunomodulatory properties.
• Biomaterials offer mechanical support and control over cell behavior in engineered tissues.
• Gene therapy, via plasmid DNA or viral vectors, provides sustained delivery of therapeutic factors, enhancing tissue regeneration.

Conclusions:

• Combining MSCs, biomaterials, and gene therapy represents an advanced strategy for musculoskeletal tissue regeneration.
• This integrated approach aims to achieve functional tissue repair by addressing key limitations in current methods.
• Further research in this combined modality holds significant potential for treating bone and cartilage defects.